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Abstract 
The study of post-translational modifications such as protein lipidation is a non-trivial challenge of 
the post-genomic era. In recent years the field of chemical proteomics has greatly advanced our ability 
to identify and quantify protein lipidation. In this mini-review we give a brief overview of the tools 
available to study protein acylation, prenylation and cholesterylation, and their application in the 
identification and quantification of protein lipidation in health and disease. 
Abbreviations: 17-ODYA, 17-octadecynoic acid; ABE, acyl-biotin exchange; acyl-RAC, resin 
assisted capture of S-acylated proteins; FTase, farnesyl transferase; FTI, farnesyl transferase inhibitor; 
Hh, Hedgehog protein; NMT, N-myristoyl transferase; PTM, post-translational modification; SILAC, 
stable isotope labelling with amino acids in cell culture 
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Introduction
Post-translational modifications (PTMs) of proteins include a host of chemical transformations that 
occur to proteins after (or occasionally during) ribosomal synthesis. A large number of reversible and 
irreversible PTMs serve to regulate protein function, activity and location within the cell. As PTMs 
are not directly encoded by the genome, they add a further layer of complexity to the proteome that is 
not readily accessible to the traditional tools of genetics. PTMs include the covalent attachment of 
small inorganic molecules (e.g. phosphorylation), carbohydrates (e.g. glycosylation), small proteins 
(e.g. ubiqutination) and lipids. Protein lipidation includes, among others, N-myristoylation [1], S- and 
N-palmitoylation [2], prenylation [3], cholesterylation [4] and the attachment of 
glycosylphosphatidylinositol (GPI) anchors [5]. 
The importance of protein lipidation in normal and dysfunctional cell regulation is mirrored in current 
programs that aim to develop therapies targeting lipidation [6-8]. Modulating or inhibiting lipidation 
has an impact in a range of pathologies, including cancer, cardiovascular disease, fungal infections, 
tropical diseases such as malaria, as well as HIV and AIDS [1, 9, 10]. 
(FIGURE 1. Protein lipid modifications and a selection of chemical probes to detect protein 
lipidation. Sonic hedgehog (Shh) is N-palmitoylated on Cys25 and O-cholesterylated on Gly198. H-
Ras is S-palmitoylated on Cys181/Cys184 and farnesylated on Cys186. Tyrosine protein kinase c-Src 
is N-myristoylated on Gly2. The insert boxes display a selection of azide/alkyne-tagged chemical 
probes available to study each lipid modification. Protein structures were generated from Protein 
Databank (http://www.rcsb.org) structures 3N1R (Shh), 5P21 (H-Ras) and 1FMK (c-Src) using The 
PyMOL Molecular Graphics System, Version 1.3 Schrödinger, LLC.) 
The identification and quantification of protein lipidation is a non-trivial challenge, particularly owing 
to the lack of any intrinsic handle enabling efficient visualisation or isolation of the lipid-modified 
proteome. Traditional means to study of protein lipidation utilises radiolabelled lipids for metabolic 
labelling coupled to autoradiography. These procedures are laborious, hazardous and require weeks to 
months of exposure time to obtain results. The development of chemical proteomics [11] in recent 
years has revolutionised the study of PTMs, in particular protein lipidation [1, 11, 12]. New chemical 
tools and techniques now allow the facile and rapid detection, identification and quantification of 
protein lipidation in a matter of days [11, 12]. 
In this short account we cover the basic principles of chemical proteomics in the study of protein 
acylation, prenylation and cholesterylation, as well as recent advances in quantitative methods to 
study these PTMs. 
Introducing a Chemical Handle on Lipidated Proteins  
The most widely applicable chemical method for labelling and isolating lipidated proteins involves 
metabolic labelling in cultured cells or enzymatic labelling in vitro with an alkyne or azide-tagged 
lipid analogue [11-19]. The small, biologically inert chemical tag is minimally disruptive allowing 
recognition and transfer onto target proteins by cellular lipid transferase enzymes. The alkyne/azide 
chemical tag provides a handle for down-stream processing, enabling further labelling of the lipidated 
protein. Tagged proteins can be ligated in vitro to secondary reporter molecules and/or affinity 
handles in highly specific chemical transformations such as the Huisgen cycloaddition or Staudinger 
ligation [11, 12, 16]. The proteins can subsequently be visualised by gel based methods or enriched by 
affinity purification. The enriched, lipidated proteome can be analysed by state of the art mass-
spectrometry (LC-MS/MS). By this method, in excess of 400 lipidated proteins can be identified in a 
single experiment [20, 21].  
Metabolic labelling with lipid analogues is applicable to each of the lipid PTMs discussed above. In 
addition, several other methods such as acyl-biotin exchange (ABE) and resin assisted capture (acyl-
RAC) have been developed for the study of protein palmitoylation and will be further detailed in 
following sections. 
(FIGURE 2. Metabolic tagging of lipidated proteins. Chemically tagged lipid probes are 
transferred to target proteins in cell culture by lipid transferase enzymes. After cell lysis the 
metabolically tagged proteins can be further functionalised by addition of secondary reporter 
molecules of choice such as biotin and/or flourophores. The flourophore enables rapid detection of 
lipidated proteins by in-gel fluorescence. The biotin affinity handle allows purification of lipidated 
proteins and further analysis and quantification by Western blots of proteomics.) 
Protein Acylation: Myristoylation and Palmitoylation 
Myristoylation and palmitoylation are the attachment of a myristate (C14) or palmitate (C16) fatty 
acid chain respectively. Myristoylation, catalysed by N-myristoyl transferase (NMT1 and NMT2 in 
humans), occurs on an N-terminal glycine, either co- or post-translationally, forming an irreversible 
amide [1]. Palmitoylation, on the other hand, is a reversible, dynamic process controlled by both 
palmitoyl acyl transferase (PAT) and palmitoyl thioesterase enzymes [22]. The palmitate moiety is 
attached to one or more internal cysteine residues via a thio-ester bond. In some instances N-
palmitoylation, resulting in an amide bond, results from the rearrangement from an S-palmitoylated 
residue [2]. 
Our group has pioneered the use of chemical tools to study protein N-myristoylation through 
metabolic labelling using azido and alkynyl tagged myristic acid analogues [15-17]. The myristic acid 
analogues are recognised by acyl-CoA synthase and converted to the corresponding CoA-thioesters, 
which then functions as a substrate for NMT [16]. The chemical tag introduced on myristoylated 
proteins enables visualisation of the myristome by gel-based methods, as well as enrichment for 
immunoblotting or proteomic analysis [23, 24]. 
Recent studies have focused on methods to identify and quantify dynamic protein palmitoylation. 
Similarly to myristoylation, palmitoylated proteins can be detected by means of azido or alkyne-
derivitised palmitoyl analogues [14, 19, 25]. Cravatt and Martin along with other groups in the field 
pioneered the use of 17-octadecynoic acid (17-ODYA) for metabolic labelling of palmitoylated 
proteins [26].  
 
The labile nature of the S-palmitoyl-cysteine thioester bond presents challenges but also advantages in 
the detection of palmitoylated proteins that are not encountered for other forms of protein lipidation. 
A number of analytical techniques including ABE [27-29], acyl-RAC [30] and isotope-coded fatty 
acid transmethylation (iFAT) [31] exploit the labile nature of the palmitate-cysteine thioester bond, 
and involve chemical transformation of the native proteome only after cell or tissue lysis. In ABE and 
acyl-RAC free thiols are capped, followed by cleavage of the palmitoyl thioester bond by 
hydroxylamine to expose a free sulfhydryl group. In ABE the free thiol is coupled to a biotin group, 
allowing enrichment on streptavidin resin. In the acyl-RAC protocol, the protein sample is instead 
incubated with a thiol-reactive resin, allowing capture and enrichment to proceed in one step. 
Although powerful, relying solely on thiol and thioester chemistry to label targets results in relatively 
high background (particularly in more complex systems) and loss of any information on the identity 
of the species (lipid or otherwise) previously bound via a thioester. 
 
In iFAT proteins are separated by SDS-PAGE, stained and each band excised before subsequent 
processing. Each band is subjected to base-catalysed transmethylation with isotopically labelled 
methanol to generate the fatty acid ester, which is subsequently extracted and identified by mass 
spectrometry. In contrast to ABE and acyl-RAC which aim to identify the palmitoylated protein and 
cannot give any information about the fatty acid modification, iFAT allows the identification and 
quantification of the modifying fatty acid [31]. Further elaboration of the iFAT protocol, such as 
immuno-purification before transmethylation, would be required to allow assignment of a particular 
lipid to a specific protein. 
 
ABE has been widely utilised to study protein palmitoylation in a range of biological systems, e.g. 
yeast [28], murine [29], human [32, 33] and African trypanosomes [34]. A recent report from the 
Rayner group [21] presented a comprehensive study of protein palmitoylation in Plasmodium 
falciparum. Analysis of late stage asexual parasites cultured in human erythrocytes using a 
combination of ABE and metabolic labelling with 17-ODYA enabled the detection of more than 400 
palmitoylated proteins. This report presents an interesting side-by-side comparison of the two most 
commonly used techniques for detecting protein palmitoylation. Each technique detected a unique 
pool of proteins, with an overlap of ca. 50%. More proteins were detected by ABE, but this technique 
was also associated with higher background. 
(TABLE 1. Summary of key advantages/disadvantages and potential applications of metabolic 
tagging, ABE/acyl-RAC and iFAT.) 
 
Prenylation and Cholesterylation 
Protein prenylation, the attachment of a farnesyl (C15) or geranylgeranyl (C20) isoprenoid to one or 
more cysteine residues located near protein C-terminus are post-translational modifications that 
modulate protein cellular localisation, signalling and degradation [3]. The transfer is catalysed by a 
dedicated transferase enzyme, farnesyl transferase (FTase) or geranylgeranyl transferase type I or II 
(GGTase-1 or GGTase-2/RabGGTase) from a pyrophosphate prenyl donor. The prenyl tail allows 
proteins to localise to the cell membrane where they can exert their function and interact with 
downstream effectors. Many key members of the Ras superfamily of proteins, including Rho and Rab 
GTPases require prenylation for correct function. As several cancers are associated with dysfunctional 
Ras signalling, prenyl transferase inhibitors have received much attention as potential anti-cancer 
treatments [10, 35]. 
Several labs [18, 24, 36, 37], including our own [13], have reported the use of chemical reporters to 
detect and identify prenylated proteins. Two different strategies are generally employed: 1) metabolic 
labelling using prenyl alcohols in cell culture or 2) in vitro prenylation with prenyl pyrophosphates 
using recombinant transferases in cell lysate or tissue homogenate. The prenyl alcohols are taken up 
by cells in culture and converted to their pyrophosphate equivalent through a poorly characterised 
isoprenoid salvage pathway [38]. For adequate incorporation of prenyl probes pre- and/or co-
treatment with statins is commonly required. Farnesyl- and geranylgeranyl pyrophosphate are 
intermediates of cholesterol biosynthesis, and hence statin treatment leads to depletion of endogenous 
isoprenoids by inhibiting the rate-limiting enzyme of the mevalonate pathway, HMG-CoA reductase. 
Labelling of the prenylated proteome is hence limited by the activity of the prenyl alcohol salvage 
pathway and competition with pools of endogenous isoprenoids. Statin treatment, however, has 
multiple effects in the cell including altered expression of several prenylated proteins [39]. 
The differential detection of farnesylated versus geranylgeranylated proteins has not yet been 
quantitatively accessed with currently available chemical tools. Reported probes are either non-
selective or suitable for specific detection of geranylgeranylation. Several studies suggest that the 
prenylation state of e.g. RhoB, a protein that can be either fanesylated or geranylgeranylated, 
promotes different functions in the cell and affects cellular localisation [9]. Furthermore, it has been 
suggested that proteins normally farnesylated, e.g. Ras proteins, are geranylgeranylated in the 
presence of farnesyl transferase inhibitors (FTIs), and this may in part explain the failure of FTIs to 
translate from promising anti-cancer drugs in cell studies to useful agents in the clinic [10, 35]. 
Protein cholesterylation is a post-translational modification required for the function and signalling of 
Hedgehog (Hh) proteins [4]. Misregulated Hh signalling is implicated in a number of cancers, 
including pancreatic carcinoma and lung adenocarcinoma. Our group recently reported the first 
chemically tagged probe for probing protein cholesterylation in live cells [14]. This probe labels Sonic 
Hh (Shh) proteins transiently over-expressed in HEK 293a cells and carcinoma cell lines. In-gel 
fluorescence analysis of the cholesterylated proteome also indicated that a number of other proteins 
may be labelled by the cholesterol probe, but their identity has yet to be established. Furthermore, the 
same paper reported the first example of tagging both Shh N-palmitoylation and O-cholesterylation in 
the same cell by metabolic labelling with a combination of mutually compatible palmitate and 
cholesterol probes. 
 
Quantification of Protein Lipidation 
A steady stream of reports published in the past few years has presented novel methodologies and 
their application to identify and quantify lipidated proteins. This development has been greatly 
facilitated by concurrent advances in sophisticated mass spectrometry, and its increasingly widespread 
availability. Current technology has sufficient resolution power to identify and quantify in excess of 
10,000 proteins from complex mixtures such as cell or tissue lysates [40]. 
In recent years quantitative proteomic techniques such as stable isotope labelling with amino acids in 
cell culture (SILAC) [41] have been utilised in combination with chemical proteomics to quantify 
protein lipidation. The combination of these techniques presents exciting opportunities to understand 
changes in protein lipidation in response to disease, drugs, treatment, as well as changes in other 
metabolic and signalling pathways in the cell. Furthermore, quantification can be used as a means to 
assess signal-to-background ratios and validate proteomics hits [20, 21]. Although these technologies 
can be costly to implement, the increased value of the data in terms of systems modelling will result in 
increasingly widespread use SILAC or other quantitative approaches in combination with chemical 
tagging. A useful variation on this theme is spike-in SILAC [42], recently developed by the Mann 
group, which may find application in the quantification of protein lipidation. 
In cases where the use of SILAC is impractical or not feasible, such as in vivo or in primary cell 
culture where the stability of the cell phenotype is limited to a few passages, other quantitative 
methods such as isobaric tagging (e.g. iTRAQ) or ICAT can prove useful. For example, ICAT has 
been applied to survey the targets of palmitoyl acyltransferase DHHC2 [43]. 
Challenges in the Field and Future Perspectives 
Whereas great advances have been made in the study of protein lipidation in vitro and in cell culture 
only a few groups have reported the use of chemical probes to study in vivo systems, for example by 
metabolic labelling with ?-alkynyl-palmitate [44] or in vitro prenylation of tissue lysates [13]. 
Metabolic labelling in mammals has not yet provided comprehensive or reliable profiling of targets, 
and further studies will be required to understand whether attendant pharmacokinetic issues (bio-
availability/distribution, metabolism, toxicity) can be overcome. However, it seems plausible that 
certain compartments of an in vivo model would be relatively accessible to metabolic labelling probes, 
at least over a limited timeframe, for example by direct introduction into the bloodstream or injection 
into specific organ or xenograft tissue. Although limited to analysis of S-acylation, protocols like 
ABE/acyl-RAC may be more straightforwardly applied to in vivo studies as all down-stream 
processing steps are done in vitro. 
To date there has been little focus on studying the metabolism of the lipid analogues used in labelling 
studies, and the assumption is commonly made that the proteins identified are modified by the probes 
used for labelling, and not their metabolites. A recent report suggests that metabolism of analogues 
does indeed occur, as one would expect for a biomimetic substrate, and that metabolism may also be 
monitored using the chemical tag [45]. Here, tools to identify both the site of modification and the 
modifying lipid species would be hugely beneficial, for example using capture-release reagents to aid 
recovery and analysis of the modified peptide that is otherwise lost in the enrichment step [46]. 
The field of chemical proteomics is revolutionising the study of protein lipidation. Although great 
advances have been made, there exist many exciting opportunities to develop new tools and better 
analytical methodologies. Equally, efforts are ongoing to expand application of the tools already at 
hand to broaden our understanding of the function and regulation of protein lipidation, and the 
potential to target it for therapeutic benefit. 
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Technique + - ?
Metabolic 
tagging
• Applicable to all lipid 
PTMs
• Amenable to live cell and 
in vitro labelling
• Transferase dependent 
lipidation  
• May require  synthesis of 
probes 
• Competition with 
endogenous lipids 
• Possible 
toxicity/metabolism/bio-
availability issues  
• Combine with click-capture 
reagents for identification 
of modified residue? 
• Tracking of lipid 
metabolism?  
ABE/
Acyl-RAC
• No perturbation of the 
biological system
• Commercially available 
reagents 
• Only applicable to 
S-palmitoylation 
• High background & false 
positive rate  
• No information on 
modifying lipid 
• Lengthy protocol (ABE)  
iFAT • No perturbation of the 
biological system 
• ID of modifying lipid 
• Commercially available 
reagents  
• Only applicable to 
S-palmitoylation 
• No information on 
modified protein  
• Combine with IP for 
protein identification?  
?



